You just read:

Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain

News provided by

Valeant Pharmaceuticals International, Inc.

Jul 19, 2016, 18:04 ET